Nektar Therapeutics NKTR Valuation Ratios and Share Stats

S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Nektar Therapeutics (NKTR)
Nektar Therapeutics (NKTR) Financials

Nektar Therapeutics (NKTR)

1.03

0.00

(0.00%)

Closed 20 November 8:00AM

Delayed by 15 minutes

1.03

0.005

(0.49%)

After Hours: 10:01AM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-28.671	-17.944	51.245	-21.353	-25.28	-39.446	-40.289	-49.801
Return on Equity (%)	-324.733	-109.907	75.475	-28.221	-35.803	-59.635	-70.391	-110.949
Return on Invested Capital (%)	-27.766	-10.393	78.594	-35.214	-36.849	-57.591	-64.868	-80.44
Operating Margin (%)	-78.689	-24.046	60.797	-343.492	-266.049	-467.06	-365.077	-278.425
Net Profit Margin (%)	-92.8	-31.423	57.094	-384.469	-290.645	-514.034	-399.976	-306.314
Book Value Per Share	0.076	0.071	9.457	7.529	5.557	3.251	1.539	0.687
Earnings Per Share	-1.002	-0.606	3.926	-2.497	-2.468	-2.824	-1.953	-1.447
Cash Per Share	0.389	0.03	1.123	0.546	1.105	0.136	0.468	0.185
Working Capital Per Share	2.311	1.697	7.812	6.049	5.676	3.83	2.534	1.465
Operating Profit Per Share	0.983	1.83	6.787	0.591	0.81	0.485	0.438	0.336
EBIT Per Share	-0.996	-0.602	3.934	-2.493	-2.465	-2.821	-1.936	-1.448
EBITDA Per Share	-0.996	-0.602	3.934	-2.493	-2.465	-2.821	-1.936	-1.448
Free Cash Flow Per Share	-1.061	-0.638	3.958	-2.41	-2.497	-2.814	-1.987	-1.483

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	153.21M	159.52M	173.53M	176.51M	180.09M	185.47M	188.56M	N/A

Key Stats and Ratios

Year End 31 December 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	187.95M	188.56M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	-605.15	N/A	N/A	N/A	-144.674	N/A
Net Profit Margin (%)	N/A	N/A	-634.519	N/A	N/A	N/A	-170.073	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	189.6M
Price to Earnings Ratio	-0.68
Price to Sales Ratio	2.08
Price to Cash Ratio	5.32
Price to Book Ratio	1.43
Dividend Yield	-

Share Statistics

Shares Outstanding	184.08M
Average Volume (1 week)	1.85M
Average Volume (1 Month)	1.73M
52 Week Change	114.58%
52 Week High	1.928
52 Week Low	0.4227

More Ratios Coming Soon!

Nektar Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions